CarMax: Analysts' New Targets, Estimates
Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
) --
Agco
(AGCO) - Get Report
estimates, target boosted at Morgan Stanley. Shares of AGCO now seen reaching $41. Estimates also upped, as the company should continue to expand its margins. Equal-weight rating.
Albermarle
(ALB) - Get Report
estimates, target boosted at Goldman. Shares of ALB now seen reaching $64. Estimates also upped, given higher sales and margins in its Polymer Solution division. Buy rating.
Atmel
(ATML)
estimates, target boosted at UBS. Shares of ATML now seen reaching $13.50, according to UBS. Estimates also upped, given higher touchscreen demand. Buy rating.
AutoZone
(AZO) - Get Report
estimates, target upped at Goldman. AZO estimates were boosted through 2013, Goldman Sachs said. Sector continues to see higher sales demand. Sell rating and new $258 price target.
BB&T
(BBT) - Get Report
estimates increased at Morgan Stanley through 2012. Earnings visibility is improving. Equal-weight rating and $32 price target.
Cardinal Health
(CAH) - Get Report
numbers increased at Goldman. CAH estimates were raised through 2013, Goldman Sachs said. Yong Yu acquisition should add to earnings. Neutral rating and new $38 price target.
Cooper Cos.
(COO) - Get Report
numbers upped at Citigroup through 2012. Higher sales are driving margin expansion. Hold rating and new $57 price target.
Salesforce.com
(CRM) - Get Report
price target higher at BofA/Merrill to $158 from $140. At CRM's Dreamforce conference the company announced database.com, a cloud database scheduled to be released in Feb 2011, Bank of America/Merrill Lynch said. Maintain Buy rating.
Salesforce.com
(CRM) - Get Report
estimates upped at Goldman through 2013. Company should continue to grow within the cloud computing area. Buy rating and $153 price target.
Cisco Systems
(CSCO) - Get Report
price target cut at BofA/Merrill to $24 from $28 on lower growth and gross margin outlook. Maintain Buy rating.
DirecTV
(DTV)
target raised at Kaufman to $49. Company will likely carry solid momentum into the new year. Buy rating.
Harley-Davidson
(HOG) - Get Report
estimates lowered at UBS through 2011. Retail sales are falling. Neutral rating and $31 price target.
Hertz
(HTZ) - Get Report
target increased at Goldman to $16. Company should be able to keep growing over the next few years. Buy rating.
CarMax
(KMX) - Get Report
estimates, target raised at Goldman. Shares of KMX now seen reaching $34, according to Goldman Sachs. Estimates also increased, given an improved pricing environment. Neutral rating.
Laboratory Corp.
(LH) - Get Report
target increased at UBS to $88. Company generates significant cash flow and should continue to grow following the Genzyme purchase. Neutral rating.
Micron
(MU) - Get Report
estimates reduced at UBS through 2012. DRAM prices continue to fall. Neutral rating and $7.50 price target.
Nike
(NKE) - Get Report
estimates, target increased at Citigroup. NKE estimates were raised through 2012. Company continues to benefit from higher shoe demand. Buy rating and new $95 price target.
National Oilwell Varco
(NOV) - Get Report
price target boosted at Credit Suisse to $69 from $60 as newbuild order cycle raises confidence in earnings, Credit Suisse said. Maintain Outperform rating.
Orexigen Therapeutics
(OREX)
price target boosted at BofA/Merrill to $11 from $8 as positive votes by FDA's advisory panel suggests that Contrave will be approved in 2011, Bank of America/Merrill Lynch said. Maintain Neutral rating.
Texas Instruments
(TXN) - Get Report
target raised at Citigroup. Shares of TXN now seen reaching $38. Notebook sales appear to be bottoming. Buy rating.
Vera Bradley
(VRA) - Get Report
numbers raised at Keybanc. Shares of VRA now seen reaching $40, according to Keybanc. Estimates also increased, as the company is seeing better direct sales. Buy rating.
This article was written by a staff member of TheStreet.